HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zirh

This article was originally published in The Rose Sheet

Executive Summary

Shiseido signs agreement to acquire 58.3% stake in the prestige men's cosmetics firm. The stake gives Shiseido a foothold in the rapidly growing Western men's skin care category, the company says. With the help of Shiseido, Zirh - which is available in 158 doors and six countries - plans to nearly double its product range and significantly increase international distribution to 40-60 countries by the end of 2002

You may also be interested in...



Zirh International Distribution Expansion Targets 25 Countries

Zirh Skin Nutrition plans to expand its international presence from a limited distribution in four countries to a global reach of more than 2,000 doors in 25 countries by the end of 2002, according to Exec VP-Sales & Marketing Brian Robinson

Zirh International Distribution Expansion Targets 25 Countries

Zirh Skin Nutrition plans to expand its international presence from a limited distribution in four countries to a global reach of more than 2,000 doors in 25 countries by the end of 2002, according to Exec VP-Sales & Marketing Brian Robinson

Zirh Product Portfolio Will Double With Fragrance, Sun Care Launches

Zirh Skin Nutrition is more than doubling its product offerings under a strategy developed with parent Shiseido. The prestige men's skin care company, which marketed 12 SKUs at the time of the Shiseido acquisition last year, expects to offer 29 by the end of 2001, according to Exec VP-Sales & Marketing Brian Robinson.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel